Tetrahydrocarbazole derivatives as ligands for g-protein coupled receptors (gpcr)
CA 2468880 A1 · Owner: Zentaris Gmbh · Inventors: Shaw, Ken; Paulini, Klaus; Muhn, Hans Peter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to novel tetrahydrocarbozole derivatives acting as ligands for G-protein coupled receptors (GPCR), especially as antagonists of gonadotropin-releasing hormone (GnRH). The invention also relates to a pharmaceutical composition containing said novel tetrahydrocarbozole derivatives, and to a method for producing the same. Furthermore, the invention, relates to the administration of tetrahydrocarbozole derivatives for the treatment of pathological conditions mediated by GPCR especially for the , inhibition of GnRH to mammals, especially humans, requiring such treatment and to the use of tetrahydrocarbozole, derivatives for producing a pharmaceutical agent for treating …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 16, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 16, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 16, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.